Immutep
IMMP
#7874
Rank
C$0.43 B
Marketcap
C$2.98
Share price
-5.29%
Change (1 day)
-3.51%
Change (1 year)

Earnings for Immutep (IMMP)

Earnings in 2024: -C$39.47 Million

According to Immutep's latest financial reports the company's current earnings are -C$0.01 Million. In 2024 the company made an earning of -C$39.47 Million a decrease over its 2023 earnings that were of -C$36.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immutep from 2008 to 2024

Annual earnings

Year Earnings Change
2024-C$39.47 Million7.23%
2023-C$36.81 Million19.67%
2022-C$30.76 Million-0.9%
2021-C$31.04 Million141.19%
2020-C$12.87 Million-27.85%
2019-C$17.84 Million36.56%
2018-C$13.06 Million21.61%
2017-C$10.74 Million-83.52%
2016-C$65.16 Million89.45%
2015-C$34.4 Million97.68%
2014-C$17.4 Million-9.05%
2013-C$19.13 Million-32.33%
2012-C$28.27 Million-9.61%
2011-C$31.28 Million48.52%
2010-C$21.06 Million538.22%
2009-C$3.3 Million32.05%
2008-C$2.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Illumina
ILMN
C$1.37 B-10,922.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
-C$27.03 Million 112.36%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
-C$0.18 Billion 1,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA